Agile Therapeutics Inc (AGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 3,813 | 3,995 | 3,002 | 2,126 | 1,761 |
| Cost of Goods | 2,003 | 1,653 | 1,425 | 2,231 | 1,527 |
| Gross Profit | 1,810 | 2,342 | 1,577 | -105 | 234 |
| Operating Expenses | 8,521 | 9,872 | 20,710 | 11,524 | 16,334 |
| Operating Income | -6,708 | -6,877 | -18,708 | -11,398 | -15,573 |
| Interest Expense | 402 | 432 | 1,004 | 823 | 872 |
| Other Income | 1,720 | 3,380 | 13,782 | 7,053 | 1,385 |
| Pre-tax Income | -5,390 | -3,929 | -5,930 | -5,168 | -15,060 |
| Income Tax | N/A | N/A | N/A | N/A | -4,675 |
| Net Income Continuous | -5,390 | -3,929 | -5,930 | -5,168 | -10,385 |
| Net Income | $-5,390 | $-3,929 | $-5,930 | $-5,168 | $-10,385 |
| EPS Basic Total Ops | -5.91 | 173.19 | -8.01 | -57.29 | -166.68 |
| EPS Basic Continuous Ops | -5.91 | 173.19 | -8.01 | -57.29 | -166.68 |
| EPS Diluted Total Ops | -5.91 | 173.19 | -8.01 | -57.29 | -166.68 |
| EPS Diluted Continuous Ops | -5.91 | 173.19 | -8.01 | -57.29 | -166.68 |
| EPS Diluted Before Non-Recurring Items | -7.76 | -9.00 | -11.50 | N/A | N/A |
| EBITDA(a) | $-6,308 | $-6,452 | $-17,608 | $-10,427 | $-14,566 |